Literature DB >> 28932509

Antiviral prophylaxis of cytomegalovirus reactivation in immune competent patients-the jury remains out.

Sara A Mansfield1, Charles H Cook2.   

Abstract

Entities:  

Year:  2017        PMID： 28932509      PMCID： PMC5594140          DOI： 10.21037/jtd.2017.06.130

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  7 in total

1.  Open-lung biopsy in patients with acute respiratory distress syndrome.

Authors:  L Papazian; P Thomas; F Bregeon; L Garbe; C Zandotti; P Saux; F Gaillat; M Drancourt; J P Auffray; F Gouin
Journal:  Anesthesiology       Date:  1998-04       Impact factor: 7.892

2.  Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.

Authors:  Meghan R Forster; Joanne Trgovcich; Peter Zimmerman; Alexander Chang; Cortland Miller; Paul Klenerman; Charles H Cook
Journal:  Antiviral Res       Date:  2009-12-11       Impact factor: 5.970

Review 3.  Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit.

Authors:  Andre C Kalil; Diana F Florescu
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

4.  Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia.

Authors:  L Papazian; A Fraisse; L Garbe; C Zandotti; P Thomas; P Saux; G Pierrin; F Gouin
Journal:  Anesthesiology       Date:  1996-02       Impact factor: 7.892

5.  Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.

Authors:  Charles H Cook; Yingxue Zhang; Daniel D Sedmak; Larry C Martin; Scott Jewell; Ronald M Ferguson
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

Review 6.  Sepsis and cytomegalovirus: foes or conspirators?

Authors:  Sara Mansfield; Marion Grießl; Michael Gutknecht; Charles H Cook
Journal:  Med Microbiol Immunol       Date:  2015-03-19       Impact factor: 3.402

7.  Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.

Authors:  Nicholas J Cowley; Andrew Owen; Sarah C Shiels; Joanne Millar; Rebecca Woolley; Natalie Ives; Husam Osman; Paul Moss; Julian F Bion
Journal:  JAMA Intern Med       Date:  2017-06-01       Impact factor: 21.873
  7 in total
  1 in total

Review 1.  Impact of cytomegalovirus load on host response to sepsis.

Authors:  Thomas Marandu; Michael Dombek; Charles H Cook
Journal:  Med Microbiol Immunol       Date:  2019-04-11       Impact factor: 3.402
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.